Evans John M. bought BEAM
June 29, 2026 · Form 4 insider transaction
Evans John M. bought 18,663 shares of Beam Therapeutics Inc. at $0.67 per share, a transaction worth $12.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,663
Price
$0.67
Total value
$12.5K
InsiderEvans John M.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after1,065,868
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The stock options were exercised and the shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.